The Currency of Our Industry Is Not Algarisms

At the time of the i po, we probably had ten, 12 people on the development team. We'd run a phase one in our r cerebral cavernous malformation programme. That development team has now grown into nearly forty people and continues to grow. And so this has become a much more complex organization where it's not just engineers, data scientists, biologists and chemists but drug developers as well.